FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944132039> ?p ?o ?g. }

• W2944132039 abstract "Drug resistance is one of the main limiting steps for the successful treatment of most cancers. Additionally, the presence of cancer cells with stem cell traits favors the process of treatment resistance, tumor recurrence, and spreading. Glutathione (GSH) is a major antioxidant intracellular molecule and has been positively correlated with the development of drug resistance. The purpose of this study was to verify whether GSH depletion potentiates the effect of chemotherapy in stem-like cells from the medulloblastoma cell line Daoy. Cells expressing normal (control tumor cells) or high levels of the pluripotency factor OCT4A (stem-like cells) were treated with a combination of BSO (glutathione inhibitor), cisplatin, and temozolomide (TMZ). Cell viability was assessed through MTT and apoptosis assays. Initially, the concentration of BSO required to deplete the GSH in both Daoy and Daoy-OCT4A cells was established (50 and 58 μM, respectively), as well as the IC50 of each chemotherapeutic drug. Both cells were sensitive to cisplatin (IC50 = 0.494 μM for Daoy and 0.215 μM for Daoy-OCT4A), but resistant to TMZ. The highest dose of TMZ used (500 μM) reduced the viability of Daoy cells to 56%, but only to 80% in Daoy-OCT4A cells, denoting the chemoresistant phenotype of these cancer stem-like cells. Next, the ideal combination of the three compounds was defined. For Daoy cells, it was BSO 50 μM + cisplatin 0.8 μM + TMZ 0.8 μM. As for Daoy-OCT4A cells, it was BSO 58 μM + cisplatin 0.215 μM + TMZ 500 μM. Daoy-OCT4A cells required a higher dose of TMZ than control Daoy cells to attain similar death rates; however, the combined treatment was effective for both cells. When combining these three drugs, a synergistic effect was observed for Daoy-OCT4A cells, reducing cell viability to ~17%, in comparison with treatment of cisplatin+TMZ alone. As for Daoy cells, an additive effect was observed and viability was reduced to ~15%, in comparison with cisplatin+TMZ alone. This indicates that the use of a glutathione inhibitor in combination with cisplatin and TMZ may be useful in the treatment of medulloblastoma, even in the case of aggressive tumors. Similarly, this approach may also be useful in the development of therapeutic strategies for other chemoresistant tumors. Citation Format: Beatriz Dias Barbieri, Marina Marcola, Clarissa Rocha, Oswaldo Keith Okamoto. Glutathione depletion overcomes chemotherapy resistance in aggressive medulloblastoma stem-like cells [abstract]. In: Proceedings of the AACR International Conference held in cooperation with the Latin American Cooperative Oncology Group (LACOG) on Translational Cancer Medicine; May 4-6, 2017; Sao Paulo, Brazil. Philadelphia (PA): AACR; Clin Cancer Res 2018;24(1_Suppl):Abstract nr A57." @default.
• W2944132039 created "2019-05-16" @default.
• W2944132039 creator A5002321293 @default.
• W2944132039 creator A5013429271 @default.
• W2944132039 creator A5028557692 @default.
• W2944132039 creator A5082856671 @default.
• W2944132039 date "2018-01-01" @default.
• W2944132039 modified "2023-09-27" @default.
• W2944132039 title "Abstract A57: Glutathione depletion overcomes chemotherapy resistance in aggressive medulloblastoma stem-like cells" @default.
• W2944132039 doi "https://doi.org/10.1158/1557-3265.tcm17-a57" @default.
• W2944132039 hasPublicationYear "2018" @default.
• W2944132039 type Work @default.
• W2944132039 sameAs 2944132039 @default.
• W2944132039 citedByCount "0" @default.
• W2944132039 crossrefType "proceedings-article" @default.
• W2944132039 hasAuthorship W2944132039A5002321293 @default.
• W2944132039 hasAuthorship W2944132039A5013429271 @default.
• W2944132039 hasAuthorship W2944132039A5028557692 @default.
• W2944132039 hasAuthorship W2944132039A5082856671 @default.
• W2944132039 hasConcept C121608353 @default.
• W2944132039 hasConcept C153911025 @default.
• W2944132039 hasConcept C190283241 @default.
• W2944132039 hasConcept C2776694085 @default.
• W2944132039 hasConcept C2778239845 @default.
• W2944132039 hasConcept C28328180 @default.
• W2944132039 hasConcept C502942594 @default.
• W2944132039 hasConcept C53227056 @default.
• W2944132039 hasConcept C54355233 @default.
• W2944132039 hasConcept C55427017 @default.
• W2944132039 hasConcept C55493867 @default.
• W2944132039 hasConcept C81885089 @default.
• W2944132039 hasConcept C86803240 @default.
• W2944132039 hasConcept C95444343 @default.
• W2944132039 hasConcept C96232424 @default.
• W2944132039 hasConceptScore W2944132039C121608353 @default.
• W2944132039 hasConceptScore W2944132039C153911025 @default.
• W2944132039 hasConceptScore W2944132039C190283241 @default.
• W2944132039 hasConceptScore W2944132039C2776694085 @default.
• W2944132039 hasConceptScore W2944132039C2778239845 @default.
• W2944132039 hasConceptScore W2944132039C28328180 @default.
• W2944132039 hasConceptScore W2944132039C502942594 @default.
• W2944132039 hasConceptScore W2944132039C53227056 @default.
• W2944132039 hasConceptScore W2944132039C54355233 @default.
• W2944132039 hasConceptScore W2944132039C55427017 @default.
• W2944132039 hasConceptScore W2944132039C55493867 @default.
• W2944132039 hasConceptScore W2944132039C81885089 @default.
• W2944132039 hasConceptScore W2944132039C86803240 @default.
• W2944132039 hasConceptScore W2944132039C95444343 @default.
• W2944132039 hasConceptScore W2944132039C96232424 @default.
• W2944132039 hasLocation W29441320391 @default.
• W2944132039 hasOpenAccess W2944132039 @default.
• W2944132039 hasPrimaryLocation W29441320391 @default.
• W2944132039 hasRelatedWork W1979831498 @default.
• W2944132039 hasRelatedWork W1980218169 @default.
• W2944132039 hasRelatedWork W2004633003 @default.
• W2944132039 hasRelatedWork W2012092425 @default.
• W2944132039 hasRelatedWork W2017936372 @default.
• W2944132039 hasRelatedWork W2051139924 @default.
• W2944132039 hasRelatedWork W2080353543 @default.
• W2944132039 hasRelatedWork W2179782203 @default.
• W2944132039 hasRelatedWork W2274345434 @default.
• W2944132039 hasRelatedWork W2309912989 @default.
• W2944132039 hasRelatedWork W2314681160 @default.
• W2944132039 hasRelatedWork W2317648039 @default.
• W2944132039 hasRelatedWork W2419860237 @default.
• W2944132039 hasRelatedWork W2462339491 @default.
• W2944132039 hasRelatedWork W2587241608 @default.
• W2944132039 hasRelatedWork W2888674289 @default.
• W2944132039 hasRelatedWork W2943087830 @default.
• W2944132039 hasRelatedWork W3081667702 @default.
• W2944132039 hasRelatedWork W3084056518 @default.
• W2944132039 hasRelatedWork W3093759451 @default.
• W2944132039 isParatext "false" @default.
• W2944132039 isRetracted "false" @default.
• W2944132039 magId "2944132039" @default.
• W2944132039 workType "article" @default.